• May 9, 2025
  • See all results
MedShadow Trademarked LogoBalancing the Risks and Benefits of Medications
Newsletter DONATE
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    Drug Classifications: Schedule I, II, III, IV, V

    Controlled Drug Classifications: Schedule I, II, III, IV, V

    older man getting an infusion, FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More

    FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More

    small child holding melatonin gummy

    Are Melatonin Supplements Safe for Kids?

    Migraine Drugs and High Blood Pressure, Circulation Problems , woman about to take tablet

    FDA SIDE EFFECTS UPDATE: Migraine Drugs and High Blood Pressure, Circulation Problems

    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    VIDEOS
    Drug Classifications: Schedule I, II, III, IV, V

    Controlled Drug Classifications: Schedule I, II, III, IV, V

    older man getting an infusion, FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More

    FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More

    small child holding melatonin gummy

    Are Melatonin Supplements Safe for Kids?

    Migraine Drugs and High Blood Pressure, Circulation Problems , woman about to take tablet

    FDA SIDE EFFECTS UPDATE: Migraine Drugs and High Blood Pressure, Circulation Problems

    FDA database updates delayed

    Mission Critical Update: Medication Safety Updates from the FDA Delayed

    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
    PODCAST

    Preventable Illnesses: Lifestyle Choices Over Medication

    Childhood Asthma and Obesity: The Road to Resilience

    Childhood Asthma and Obesity: The Road to Resilience

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Creativity in Veganism, and Discovering Vegan Life Balance

    Creativity in Veganism, and Discovering Vegan Life Balance

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

  • INFOGRAPHICS
  • Login / Signup
  • Search
Home
Public Health - Government & Society
FDA
Latest
  • Latest
  • Oldest
  • Random
  • A to Z

FDA

FDA database updates delayed
MedShadow Articles

Mission Critical Update: Medication Safety Updates from the FDA Delayed

Emma Yasinski
FDA Drug Recalls and Warnings: Websites Selling Illegal GLP-1s, concerned doctor looking at computer
MedShadow Articles

FDA Drug Recalls and Warnings: Websites Selling Illegal GLP-1s, Plus More

Katie Rowley
FDA SIDE EFFECTS Update, pharmacist in pharmacy
MedShadow Articles

FDA SIDE EFFECTS UPDATE: Paxil’s Impact On Pregnancy & More

Katie Rowley
fda safety update, pills
MedShadow Articles

FDA Side Effect Update: Ayvakit, Brilinta, Caduet, and More

Katie Rowley
fda safety update, pills
MedShadow Articles

FDA Side Effects Update: Jylamvo, Limbitrol, Liptruzet, and More

Katie Rowley
What to Know About the Right to Try Law in 2024What to Know About the Right to Try Law in 2024
MedShadow Articles

Choices For The Terminally Ill: FDA’S Expanded Access Program Or Right To Try Act?

Jessica DiGiacinto
misinformation on ocial media
Medication Articles

FDA Provides Guidance to Pharma Companies for Correcting Social Media Misinformation

Emma Yasinski
Open Letter to the FDA: You’re Protecting the Wrong PeopleSu Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data
FDA

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti
Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?
MedShadow Articles

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

Emma Yasinski
FDA
FDA

Judge vs. FDA: Drug Safety and Effectiveness

Suzanne B. Robotti
FDA Advisory Committee and FDA Drug Approval
FDA

Advice for FDA Drug Approvals

Suzanne B. Robotti
Family Dollar Recall
FDA

Family Dollar Products Recalled Due to Contamination

Emma Yasinski
The Purple Pill Problem: PPIs, GERD and Serious Side Effects
GERD

The Purple Pill Problem: PPIs, GERD and Serious Side Effects

Janice Leary
Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine
COVID-19

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Jonathan Block
The FDA Says Boo To Black Licorice
FDA

The FDA Says Boo To Black Licorice

Alanna McCatty
How Safe Are Generic Drugs?
Featured Articles

How Safe Are Generic Drugs?

Diane Archer
Quick Hits
Quick Hits

Quick Hits: FDA Reports Senior Drug Adverse Events & More

Emma Yasinski
FDA Warnings About Fluoroquinolone Antibiotics
Downloadables

FDA Warnings About Fluoroquinolone Antibiotics

MedShadow
Quick Hits
Quick Hits

Quick Hits: Interim FDA Head Named, Inactive Ingredients & More

Suzanne B. Robotti
Scott Gottlieb’s FDA Legacy
FDA

Scott Gottlieb’s FDA Legacy

Jonathan Block
Load More

ABOUT MEDSHADOW

Medications have many benefits, but it’s essential to know how to balance these against their potential side effects. MedShadow is a nonprofit foundation that focuses on the safest ways to take over-the-counter (OTC) and prescription (Rx) medications. Our name derives from the fact that side effects can sometimes be difficult to recognize, which is why we work to illuminate and explain medication reactions that may be minimized or obscured.

We also help people factor in integrative health and medicine options and provide information about lifestyle changes to optimize one’s health. Whatever decision a person makes, our goal is to be supportive.

At MedShadow, our mission is to provide independent, evidence-and science-based information. Our service and investigative journalism enables people to make informed decisions and we strive to stimulate public conversation aimed at reforming the drug manufacturing processes to ensure that we are all better protected.

We do not receive any financial support from the pharmaceutical or supplement industries and we require that all our staff, writers, advisors and other partners also be free from any remunerative relationships with such companies.

SERVICES

  • ACCOUNT
    • Become an Insider
    • Login
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Medical Advisors
    • Writers
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • PODCAST
  • VIDEOS
  • INFOGRAPHICS
  • CONTACT US
Balancing the Risks and Benefits of Medications
Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.
  • TERMS
  • Ad Guidelines
  • Privacy Policy
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
  • INFOGRAPHICS
Newsletter DONATE
Newsletter JOIN
Start typing to see results or hit ESC to close
FDA side effects depression Opioids cancer
See all results
Username
Password
Lost password?
Create an account
Enter username or email
Cancel